Unit of Geriatric Cardiology and Medicine, Department of Critical Care Medicine and Surgery, University of Florence, Viale Pieraccini 6, 50141 Florence, Italy.
Eur Heart J. 2010 Aug;31(16):2021-6. doi: 10.1093/eurheartj/ehq017. Epub 2010 Feb 18.
We evaluated the early (1 month) and late (2 years) death rate and syncopal relapses of patients referred for syncope to 11 general hospitals emergency departments. Patients were enrolled in the Evaluation of Guidelines in SYncope Study 2 (EGSYS 2) study. The guidelines of the European Society of Cardiology were strictly followed in the management of patients.
Out of the 465 patients enrolled in the EGSYS 2 study, 398 (86%) underwent a complete follow-up. We excluded 18 patients with non-syncopal attacks. Among the remaining 380 patients, death of any cause occurred in 35 (9.2%). The mean follow-up was 614 +/- 73 days. Six deaths (17% of total) occurred during the first month of follow-up. Patients who died were older, had a higher incidence of structural heart disease and/or abnormal ECG, had injuries related to syncope and higher EGSYS score. Syncope recurred in 63 (16.5%) patients. Syncopal relapses occurred in only one patient during the first month of follow-up. The incidence of syncopal recurrences was unrelated to the mechanism of syncope. No clinical differences were found between patients with or without syncopal recurrence and in patients with EGSYS score < or >or=3.
A peak of cardiovascular mortality but not of syncopal recurrences was observed in patients attending to the emergency department for syncope within the first month. Late unfavourable outcomes were caused by associated cardiovascular diseases rather than by the mechanism of syncope. The causes of syncope did not determine the recurrence rate.
我们评估了因晕厥而被转诊至 11 家综合医院急诊科的患者的早期(1 个月)和晚期(2 年)死亡率和晕厥复发率。患者被纳入评估晕厥指南研究 2(EGSYS 2)研究。在患者管理中严格遵循欧洲心脏病学会的指南。
在 EGSYS 2 研究中,纳入了 465 例患者,其中 398 例(86%)完成了完整随访。我们排除了 18 例非晕厥发作的患者。在剩余的 380 例患者中,任何原因导致的死亡有 35 例(9.2%)。平均随访时间为 614 +/- 73 天。前 1 个月的随访中,有 6 例死亡(占总死亡人数的 17%)。死亡患者年龄较大,结构性心脏病和/或心电图异常发生率较高,晕厥相关损伤和 EGSYS 评分较高。63 例(16.5%)患者出现晕厥复发。在前 1 个月的随访中,仅有 1 例患者出现晕厥复发。晕厥复发的发生率与晕厥机制无关。在有无晕厥复发的患者之间,以及 EGSYS 评分<或>=3 的患者之间,未发现临床差异。
在因晕厥而就诊急诊科的患者中,在第一个月内观察到心血管死亡率的高峰,但晕厥复发率没有增加。晚期不良预后是由相关心血管疾病引起的,而不是由晕厥机制引起的。晕厥的病因并不能决定复发率。